cancer

Pfizer's Other Big News

Pfizer has confirmed plans to file its promising breast cancer drug palbociclib for FDA approval in the third quarter. If approved,...

Does Pfizer Offer Good Value?

Over the past 12 months, Pfizer has underperformed the S&P 500 by a wide margin. The company is just 4.6% ahead of the benchmark over...